2025-01-19202310.1200/PO.23.00299https://doi.org/10.1200/PO.23.00299https://hdl.handle.net/20.500.14288/26006OncologyExceptional response to MEK inhibition in a patient with RAF1-Mutant myxofibrosarcoma: case report and mechanistic overviewJournal Article2473-42841208474300001Q150441